Page 3 - Serum Institute Of India

Risk-taker gets a booster dose: Meet Adar Poonawalla, CEO, Serum Institute

SII invests 90-95 per cent of its profits every year to build capacities

UK marks Oxford/AstraZeneca Covid-19 vaccine's one-year anniversary

Our fight against COVID in the UK and around the world would not have been possible without the Oxford/AstraZeneca vaccine, said PM Boris Johnson

Vaccine makers bet global demand, boosters will drive growth next year

Domestic demand had fallen after cases began to decline. Omicron surge may reverse the trend

Covid LIVE: Mumbai, Delhi again report sharp rise in daily new cases

2,510 new Covid cases reported in Mumbai on Wednesday, 82% higher than Tuesday, while Delhi reports 86% jump at 923 new infections

DCGI seeks more data from SII over emergency authorisation for Covovax

'The apex drug regulator has also asked the SII to provide details on Matrix component used in the vaccine,' an official source said

Serum Institute on the up as Oxford study backs AstraZ booster for Omicron

Vaxzevria significantly boosts antibodies against the rapidly spreading variant of the coronavirus, shows study

Adar Poonawalla picks up 20% stake in social media platform Wakau

Wakau offers a combination of mobile-first screen experience and short video content in entertainment and fashion domains

Serum Institute CEO hails WHO's approval of Covovax for emergency use

Serum Institute of India (SII) CEO Adar Poonawalla on Friday hailed WHO's approval for emergency use of Covovax vaccine for children "as yet another milestone" in the fight against COVID-19. The World Health Organization (WHO) on Friday listed the Covovax as the ninth COVID-19 vaccine for emergency use with an aim to increase the access to vaccination in lower-income countries. It is produced by the Serum Institute of India under the licence from Novavax. Reacting to the development, Poonawalla tweeted, "This is yet another milestone in our fight against COVID-19, Covovax is now WHO approved for emergency use, showing excellent safety and efficacy. Thank you all for a great collaboration..." He tagged Novavax, WHO, Gavi, the Vaccine Alliance, its CEO Seth Berkley and the Gates Foundation. Earlier this week, Poonawalla had said that SII planned to launch Covovax, a COVID-19 vaccine for children in the next six months. He had stated that Covovax which is under trial would offer ...

Booster shots proven strategy to get antibodies up: Serum's Adar Poonawalla

Says policy makers must decide risk-reward of giving a booster dose; Serum Institute has reached trial phase of vaccine for kids above 3, jab should be ready to launch in six months

No recommendations for Covid booster dose by SEC: Report

The SEC was reviewing the application of the Serum Institute of India (SII) for the booster dose in a meeting that took place on Friday.

Pandemic-hit 2021 sees top Indian cos' valuation rise 68%: Hurun report

The list is led by Mukesh Ambani-led Reliance Industries

Will vaccine crunch hurt India's ongoing fight against Covid-19?

Serum Institute is going to cut down production of Covishield as there's no order from the govt. But some states don't have enough vaccine in store. Find out if India is well-stocked to fight Covid-19

Serum may cut Covishield's monthly production by half as govt orders dry up

The Pune-based firm has 500 million doses of Covishield in stock

SII may cut Covishield's monthly production by half amid demand slump

SII has written to the government to seek clarity on its requirement for normal two doses and also on booster doses

SII seeks DCGI's approval for Covishield as booster dose: Report

In an application to DCGI, an SII official cited that the UK's Medicines and Healthcare products Regulatory Agency has already approved the booster dose of AstraZeneca's vaccine, say sources

SII resumes exports to COVAX, produces 1.25 bn Covishield doses this year

The first batches of Covishield left the SII manufacturing facility in Pune earlier today, for distribution to low- and middle-income countries

Serum Institute resumes Covishield exports under COVAX facility

SII said its supply of doses via COVAX was expected to increase substantially into the first quarter of 2022

Covid-19 jab exports set to rise; Serum Institute leads the pack

Indonesia to get 5 mn Covovax doses, exports to COVAX to rise to 30 mn by Jan

Serum Institute urges govt to speed up movement of rising Covishield stock

Serum Institute of India has urged the government to fast-track Covishield movement citing the difficulties being faced in production and cold chain space planning for other vaccines

Vaccine hesitancy greatest threat in overcoming Covid: Adar Poonawalla

Serum Institute of India CEO Adar Poonawalla on Wednesday termed vaccine hesitancy as the greatest threat in overcoming the COVID-19 pandemic while urging all adults to get vaccinated at the earliest